research use only

Topotecan (SKF 104864A) Topo I Inhibitor

Cat.No.S9321

Topotecan(NSC609699,Nogitecan,SKFS 104864A) is an antineoplastic agent used to treat ovarian cancer that works by inhibiting DNA topoisomerases.
Jump to

Quality Control

Batch: Purity: 99.94%
99.94

Solubility

In vitro
Batch:

DMSO : 84 mg/mL (199.31 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : ˂1 mg/mL

Ethanol : ˂1 mg/mL

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 421.45 Formula

C23H23N3O5

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 123948-87-8 -- Storage of Stock Solutions

Synonyms NSC609699,Nogitecan,SKFS 104864A SMILES CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O

Read more about storage stability stock solution CAS number SMILES

Mechanism of Action

Targets/IC50/Ki
Topo I
In vitro

Topotecan exhibits inhibition of outgrowth of the highly invasive and migratory leader cells (LC) population, however, topotecan enrichs the LC subset 20% above the untreated control level.

In vivo

Topotecan (TPT), at least in part by inhibiting expression of Fli-1, significantly ameliorates lupus nephritis in NZBWF1 mice as effectively or better than cyclophosphamide (CYC).

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2026-02-12)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05535166 RECRUITING
Medulloblastoma
St. Jude Children's Research Hospital
2022-12-20 PHASE2
NCT04681417 RECRUITING
Retinoblastoma
Institut Curie
2021-03-25 PHASE2; PHASE3
NCT07321912 RECRUITING
Osteosarcoma; Ewing Sarcoma
Milton S. Hershey Medical Center
2026-06-05 PHASE2
NCT05521984 RECRUITING
Pediatric Brain Tumor; Pediatric Solid Tumor
Washington University School of Medicine
2023-04-03 PHASE1
NCT02813135 RECRUITING
Pediatric Cancer
Gustave Roussy, Cancer Campus, Grand Paris
2016-08-03 PHASE1; PHASE2
NCT07334301 RECRUITING
Relapsed Neuroblastoma
University of Birmingham
2024-11-11 PHASE1; PHASE2

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map